Stativer

Hypercholesterolemia and Cardiovascular Prevention

Hypercholesterolemia

• Treatment of primary hypercholesterolemia or mixed dyslipidemia, as a nutritional supplement, when response to diet and other non-pharmacological agents is inadequate
• Treatment of homozygous familial hypercholesterolemia, as a supplement to diet and other lipid-lowering therapies

Cardiovascular Prevention

• Reduced cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with normal or elevated cholesterol levels, as a supplement to the coverage of other risk factors and other cardioprotective therapy